EMD Serono Overview
- Status
-
Private
- Employees
-
1,852
- Investments
-
2
EMD Serono General Information
Description
EMD Serono is a biotechnology company that discovers and develops biopharmaceutical products. It focuses on specialized areas, such as neurodegenerative diseases, fertility, metabolic endocrinology and oncology. The company was founded in 1971 and is headquartered in Rockland, Massachusetts. It seeks to acquire other companies in the same line of business to develop even more and grow its portfolio of products.
Contact Information
Website
www.emdserono.comCorporate Office
- 200 Pier 4 Boulevard
- Boston, MA 02210
- United States
Corporate Office
- 200 Pier 4 Boulevard
- Boston, MA 02210
- United States
EMD Serono Comparisons
Industry
Financing
Details
EMD Serono Competitors (32)
One of EMD Serono’s 32 competitors is Novartis, a Corporation company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novartis | Corporation | Basel, Switzerland | ||||
| GSK | Corporation | London, United Kingdom | ||||
| Nevian Lifescience | Corporate Backed or Acquired | Dhaka, Bangladesh | ||||
| Lilly USA | Corporation | Indianapolis, IN | ||||
| Santhera Pharmaceuticals Holding | Formerly VC-backed | Pratteln, Switzerland |
EMD Serono Patents
EMD Serono Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20070270339-A1 | Use of gpcr54 ligands for the treatment of infertility | Inactive | 23-Apr-2004 | ||
| AU-2001261370-A1 | Nucleic acids encoding polypeptides related to the alpha subunit of the glycoprotein hormone family and methods of use thereof | Inactive | 08-May-2000 | ||
| WO-2001085783-A2 | Nucleic acids encoding polypeptides related to the alpha subunit of the glycoprotein hormone family and methods of use thereof | Inactive | 08-May-2000 | ||
| WO-2001085783-A3 | Nucleic acids encoding polypeptides related to the alpha subunit of the glycoprotein hormone family and methods of use thereof | Inactive | 08-May-2000 | C07K14/575 |
EMD Serono Signals
EMD Serono Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Emd Serono Holding | Boston, MA | 2011 | |
| Emd Accounting Solutions & Services America | Rockland, MA | 2010 |
EMD Serono FAQs
-
Where is EMD Serono headquartered?
EMD Serono is headquartered in Boston, MA.
-
What is the size of EMD Serono?
EMD Serono has 1,852 total employees.
-
What industry is EMD Serono in?
EMD Serono’s primary industry is Pharmaceuticals.
-
Is EMD Serono a private or public company?
EMD Serono is a Private company.
-
What is EMD Serono’s current revenue?
The current revenue for EMD Serono is .
-
Who are EMD Serono’s competitors?
Novartis, GSK, Nevian Lifescience, Lilly USA, and Santhera Pharmaceuticals Holding are some of the 32 competitors of EMD Serono.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process